Yonatan Kindie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yonatan Kindie has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Adane Adugna
Department of Medical Laboratory Science, College of Medicine and Health Sciences, Debre Markos University, Debre Markos, Ethiopia
2 shared publications - Bantayehu Addis Tegegne
Department of Pharmacy, College of Medicine and Health Science, Debre Markos University, Debre Markos, Ethiopia
2 shared publications Desalegn Abebaw
Debremarkos University
2 shared publications- Desalegn Abebaw
Department of Medical Laboratory Science, College of Medicine and Health Sciences Debre Markos University Debre Markos Ethiopia
2 shared publications Habtamu Belew
Debremarkos University
2 shared publicationsZigale Hibstu Teffera
Department of Medical Laboratory Science, College of Medicine and Health Sciences Debre Markos University Debre Markos Ethiopia
2 shared publications
Latest Publications
- Open Access
- 16 October 2026
- Published by Wiley in Immunology
Epigenetic and Metabolic Changes That Drive Trained Immunity in Response to Microbes and Vaccines
Trained immunity is a form of innate immune memory in which initial exposure to microbial components or vaccines leads to long‐lasting functional reprogramming of innate immune cells through epigenetic and metabolic changes. Unlike adaptive immunity, it does not rely on B or T lymphocytes and provides broad, nonspecific protection against various pathogens. This phenomenon has been observed across a range of immune cells, including monocytes, macrophages, neutrophils, NK cells and even γδ T‐cells, as well as at the level of haematopoietic stem and progenitor cells (HSPCs). Key inducers include microbial products (e.g., β‐glucan, BCG and MMR vaccines), metabolic byproducts (e.g., mevalonate and lactate) and cytokines such as IL‐1β. These agents activate signalling pathways such as the Akt/mTOR/HIF‐1α pathway and lead to chromatin remodelling via histone modifications such as H3K4me3 and H3K9me3. Immunometabolism plays a pivotal role, with trained cells shifting toward glycolysis, glutaminolysis and cholesterol synthesis. Lactate and fumarate further link metabolism to epigenetic remodelling. Notably, trained immunity can be protective in infectious diseases and beneficial in noninfectious contexts, such as cancer immunotherapy and autoimmune regulation. This review provides a comprehensive overview of the cellular, epigenetic and metabolic mechanisms underlying trained immunity, highlighting how innate immune cells acquire memory‐like properties independent of adaptive immunity. This study also provides insights into the therapeutic potential of leveraging trained immunity for vaccine development, infection control and immunomodulation in noninfectious diseases.
- 16 October 2026
- Published by Wiley in Immunology
Open AccessEpigenetic and Metabolic Changes That Drive Trained Immunity in Response to Microbes and Vaccines
Trained immunity is a form of innate immune memory in which initial exposure to microbial components or vaccines leads to long‐lasting functional reprogramming of innate immune cells through epigenetic and metabolic changes. Unlike adaptive immunity, it does not rely on B or T lymphocytes and provides broad, nonspecific protection against various pathogens. This phenomenon has been observed across a range of immune cells, including monocytes, macrophages, neutrophils, NK cells and even γδ T‐cells, as well as at the level of haematopoietic stem and progenitor cells (HSPCs). Key inducers include microbial products (e.g., β‐glucan, BCG and MMR vaccines), metabolic byproducts (e.g., mevalonate and lactate) and cytokines such as IL‐1β. These agents activate signalling pathways such as the Akt/mTOR/HIF‐1α pathway and lead to chromatin remodelling via histone modifications such as H3K4me3 and H3K9me3. Immunometabolism plays a pivotal role, with trained cells shifting toward glycolysis, glutaminolysis and cholesterol synthesis. Lactate and fumarate further link metabolism to epigenetic remodelling. Notably, trained immunity can be protective in infectious diseases and beneficial in noninfectious contexts, such as cancer immunotherapy and autoimmune regulation. This review provides a comprehensive overview of the cellular, epigenetic and metabolic mechanisms underlying trained immunity, highlighting how innate immune cells acquire memory‐like properties independent of adaptive immunity. This study also provides insights into the therapeutic potential of leveraging trained immunity for vaccine development, infection control and immunomodulation in noninfectious diseases.
- Open Access
- 11 October 2026
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 19
Metabolic syndrome and hormonal correlates of its predominant components among postmenopausal women: An institution-based cross-sectional study
Background: Metabolic syndrome is a multifactorial condition strongly associated with cardiovascular disease and diabetes. Hormonal alterations during menopause increase women’s susceptibility to metabolic syndrome. Therefore, determination of metabolic syndrome, its components and investigation of the association of sex steroid hormones with predominant components provide context-specific evidence. Objective: To assess the prevalence of metabolic syndrome, its predominant components and investigate the correlation of reproductive hormones with its predominant components among postmenopausal women. Design: An institution based cross sectional study was conducted among 422 women. Methods: The study participants were selected using systematic random sampling technique. Serum triglycerides, HDL cholesterol, fasting glucose and reproductive hormones were measured using a Beckman Coulter analyzer. Data were analyzed using SPSS version 27. Correlation analysis was made to assess the strength and direction of relationship between reproductive hormones and metabolic syndrome components. Multivariable logistic regression was employed to identify factors associated with the prevalence of metabolic syndrome. Statistical significance was determined at p < 0.05 and results reported as odds ratios with 95% confidence intervals. Results: The prevalence of metabolic syndrome was 38.4% (95% CI: 33.9–43.1). Low HDL cholesterol was the most prevalent component (91.9%). Physical inactivity, nulliparity and history of hormonal contraceptive use were significantly associated with increased odds of metabolic syndrome. Higher Estrogen levels demonstrated a protective effect, whereas FSH and LH were significantly associated with adverse metabolic components including increased waist circumference, triglycerides, fasting blood glucose and reduced HDL cholesterol. Conclusion: Metabolic syndrome was highly prevalent, with low HDL cholesterol as the dominant abnormality. Gonadotropins showed stronger associations with adverse cardiometabolic biomarkers than Estrogen. Lifestyle modification and early screening are essential to reduce cardiometabolic risk among menopausal women.
- 11 October 2026
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 19
Open AccessMetabolic syndrome and hormonal correlates of its predominant components among postmenopausal women: An institution-based cross-sectional study
Background: Metabolic syndrome is a multifactorial condition strongly associated with cardiovascular disease and diabetes. Hormonal alterations during menopause increase women’s susceptibility to metabolic syndrome. Therefore, determination of metabolic syndrome, its components and investigation of the association of sex steroid hormones with predominant components provide context-specific evidence. Objective: To assess the prevalence of metabolic syndrome, its predominant components and investigate the correlation of reproductive hormones with its predominant components among postmenopausal women. Design: An institution based cross sectional study was conducted among 422 women. Methods: The study participants were selected using systematic random sampling technique. Serum triglycerides, HDL cholesterol, fasting glucose and reproductive hormones were measured using a Beckman Coulter analyzer. Data were analyzed using SPSS version 27. Correlation analysis was made to assess the strength and direction of relationship between reproductive hormones and metabolic syndrome components. Multivariable logistic regression was employed to identify factors associated with the prevalence of metabolic syndrome. Statistical significance was determined at p < 0.05 and results reported as odds ratios with 95% confidence intervals. Results: The prevalence of metabolic syndrome was 38.4% (95% CI: 33.9–43.1). Low HDL cholesterol was the most prevalent component (91.9%). Physical inactivity, nulliparity and history of hormonal contraceptive use were significantly associated with increased odds of metabolic syndrome. Higher Estrogen levels demonstrated a protective effect, whereas FSH and LH were significantly associated with adverse metabolic components including increased waist circumference, triglycerides, fasting blood glucose and reduced HDL cholesterol. Conclusion: Metabolic syndrome was highly prevalent, with low HDL cholesterol as the dominant abnormality. Gonadotropins showed stronger associations with adverse cardiometabolic biomarkers than Estrogen. Lifestyle modification and early screening are essential to reduce cardiometabolic risk among menopausal women.
- Open Access
- 21 September 2026
- Published by Elsevier in Obesity Pillars
- Vol. 20
Association between diet quality and overweight or obesity among adults with type 2 diabetes at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia
- 21 September 2026
- Published by Elsevier in Obesity Pillars
- Vol. 20
Open AccessAssociation between diet quality and overweight or obesity among adults with type 2 diabetes at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia
- Open Access
- 26 August 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (9) , e73144
Serum Albumin and Uric Acid Levels Among Hypertensive Patients in Northwest Ethiopia: A Comparative Cross‐Sectional Study
Background and Aims: Hypertension is a long‐term condition marked by consistently high arterial blood pressure. Hypertensive patients often experience altered serum albumin and uric acid, attributed to factors like inflammation, kidney damage, and the activation of the renin angiotensin aldosterone system. However, localized evidence regarding these biomarkers remains scarce within the Ethiopian context. This study aimed to assess the level of serum albumin and uric acid among hypertensive patients. Methods: A comparative cross‐sectional study was conducted from March 1 to May 30, 2025, involving 232 study participants selected using systematic random sampling. Of these, 116 were patients with hypertensive and 116 were normotensives. Sociodemographic, behavioral, and clinical data were measured by structured questionnaires. Serum albumin and uric acid levels were measured by spectrophotometric principle. Data were analyzed using SPSS version 25 software. Descriptive statistics, independent t ‐tests, and binary logistic regression were performed with significance set at p < 0.05. Results: The mean age of the study participants was 46 ± 11.4 and 45 ± 11.6 for the case and control groups. There was a statistically significant difference in mean serum albumin and uric acid levels between the case and control groups. The prevalence of hypoalbuminemia and hyperuricemia among hypertensive patients were 25.9% (95% CI: 18.2%, 34.8%) and 23.3% (95% CI: 15.9%, 32%), respectively. Multivariable logistic regression showed hypertensive patients with albuminuria had 3.3 and 16.1 odds of developing hypoalbuminemia and hyperuricemia. Conclusion: This study demonstrates that the prevalence of hypoalbuminemia and hyperuricemia was higher in hypertensive patients than the controls. Albuminuria was a significant predictor of hypoalbuminemia and hyperuricemia. This underscores the potential metabolic alterations that may be associated with hypertension. Thus, it is important to monitor these parameters in hypertensive individuals.
- 26 August 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (9) , e73144
Open AccessSerum Albumin and Uric Acid Levels Among Hypertensive Patients in Northwest Ethiopia: A Comparative Cross‐Sectional Study
Background and Aims: Hypertension is a long‐term condition marked by consistently high arterial blood pressure. Hypertensive patients often experience altered serum albumin and uric acid, attributed to factors like inflammation, kidney damage, and the activation of the renin angiotensin aldosterone system. However, localized evidence regarding these biomarkers remains scarce within the Ethiopian context. This study aimed to assess the level of serum albumin and uric acid among hypertensive patients. Methods: A comparative cross‐sectional study was conducted from March 1 to May 30, 2025, involving 232 study participants selected using systematic random sampling. Of these, 116 were patients with hypertensive and 116 were normotensives. Sociodemographic, behavioral, and clinical data were measured by structured questionnaires. Serum albumin and uric acid levels were measured by spectrophotometric principle. Data were analyzed using SPSS version 25 software. Descriptive statistics, independent t ‐tests, and binary logistic regression were performed with significance set at p < 0.05. Results: The mean age of the study participants was 46 ± 11.4 and 45 ± 11.6 for the case and control groups. There was a statistically significant difference in mean serum albumin and uric acid levels between the case and control groups. The prevalence of hypoalbuminemia and hyperuricemia among hypertensive patients were 25.9% (95% CI: 18.2%, 34.8%) and 23.3% (95% CI: 15.9%, 32%), respectively. Multivariable logistic regression showed hypertensive patients with albuminuria had 3.3 and 16.1 odds of developing hypoalbuminemia and hyperuricemia. Conclusion: This study demonstrates that the prevalence of hypoalbuminemia and hyperuricemia was higher in hypertensive patients than the controls. Albuminuria was a significant predictor of hypoalbuminemia and hyperuricemia. This underscores the potential metabolic alterations that may be associated with hypertension. Thus, it is important to monitor these parameters in hypertensive individuals.
- Open Access
- 28 May 2026
- Published by SAGE Publications in Therapeutic Advances in Infectious Disease
- Vol. 13
Bacterial neonatal sepsis, antimicrobial resistance, and risk factors among neonates in Ethiopia: a systematic review and meta-analysis
Background: Antimicrobial resistance and bacterial neonatal sepsis are major threats causing high morbidity and mortality among neonates in developing countries, including in Ethiopia. Given the lack of comprehensive and synthesized evidence on the magnitude of the bacterial profile, neonatal sepsis, and antimicrobial resistance among neonates, this systematic review and meta-analysis were initiated to address this gap. Objective: The aim of this meta-analysis aims to assess the prevalence, antimicrobial resistance patterns, and risk factors of neonatal sepsis in Ethiopian neonates. Design: Systematic review and meta-analysis were conducted among Ethiopian neonates. Data source and methods: Preferred reporting item for systematic review and meta-analysis ( PRISMA) was used to screen the identified studies. We conducted a systematic search of various electronic databases including PubMed/MEDLINE, Cochrane Library, African Journals Online (AJOL), Web of Science, Grey literature and Google Scholar. The data were extracted in Microsoft Excel using a standardized data extraction format by two authors. The analysis was carried out with STATA version 17. To detect heterogeneity across studies, the I 2 and the Cochrane Q test statistics were computed. To determine the overall pooled prevalence, a random-effect meta-analysis model was used. This systematic review and meta-analysis were performed according to the updated guidelines, rigorous meta-analytical methodologies to ensure accuracy and reliability. Results: Of 9013 retrieved articles, 20 studies containing 11,754 neonates with a total of 3168 bacterial isolates (837 Gram-positive, 2328 Gram-negative). The predominant bacteria identified were: Klebsiella pneumoniae (1343), Escherichia coli (854), Staphylococcus aureus (356), other Klebsiella spp (234), CoNS (192), Acinetobacter species (172), GBS (164). The overall pooled prevalence of bacterial neonatal sepsis and multi-drug resistance (MDR) were 29.92% (25.79–34.05) and 66.20 (55.43–76.97). The subgroup analysis of this systematic review further revealed that the highest prevalence was observed in Oromia (31.62%) and Amhara (31.56%). The isolated bacteria were more resistant to penicillin groups, cephalosporins, and aminoglycosides. Preterm birth AOR = 8.2, 95%CI: 1.12–15.77), premature rupture of membranes (AOR = 4.8, 95%CI: 3.17–12.77), history of urinary tract infection at antenatal care (AOR = 33.21, 95%; 3.2–63.21), and low birth weight (AOR = 13.73, 95%CI: 4.48–31.95) were significantly associated with bacterial neonatal sepsis. Conclusion: Bacterial neonatal sepsis and MDR have been relatively high. Preterm birth, premature rupture of membranes, history of urinary tract infection at antenatal care, and low birth weight were significantly associated. Implementing antimicrobial stewardship and regular surveillance to control antimicrobial resistance is vital for informing region-specific antibiotic use. Furthermore, early diagnosis and proactive screening for risk factors are key to preventing neonatal sepsis and decreasing its overall burden.
- 28 May 2026
- Published by SAGE Publications in Therapeutic Advances in Infectious Disease
- Vol. 13
Open AccessBacterial neonatal sepsis, antimicrobial resistance, and risk factors among neonates in Ethiopia: a systematic review and meta-analysis
Background: Antimicrobial resistance and bacterial neonatal sepsis are major threats causing high morbidity and mortality among neonates in developing countries, including in Ethiopia. Given the lack of comprehensive and synthesized evidence on the magnitude of the bacterial profile, neonatal sepsis, and antimicrobial resistance among neonates, this systematic review and meta-analysis were initiated to address this gap. Objective: The aim of this meta-analysis aims to assess the prevalence, antimicrobial resistance patterns, and risk factors of neonatal sepsis in Ethiopian neonates. Design: Systematic review and meta-analysis were conducted among Ethiopian neonates. Data source and methods: Preferred reporting item for systematic review and meta-analysis ( PRISMA) was used to screen the identified studies. We conducted a systematic search of various electronic databases including PubMed/MEDLINE, Cochrane Library, African Journals Online (AJOL), Web of Science, Grey literature and Google Scholar. The data were extracted in Microsoft Excel using a standardized data extraction format by two authors. The analysis was carried out with STATA version 17. To detect heterogeneity across studies, the I 2 and the Cochrane Q test statistics were computed. To determine the overall pooled prevalence, a random-effect meta-analysis model was used. This systematic review and meta-analysis were performed according to the updated guidelines, rigorous meta-analytical methodologies to ensure accuracy and reliability. Results: Of 9013 retrieved articles, 20 studies containing 11,754 neonates with a total of 3168 bacterial isolates (837 Gram-positive, 2328 Gram-negative). The predominant bacteria identified were: Klebsiella pneumoniae (1343), Escherichia coli (854), Staphylococcus aureus (356), other Klebsiella spp (234), CoNS (192), Acinetobacter species (172), GBS (164). The overall pooled prevalence of bacterial neonatal sepsis and multi-drug resistance (MDR) were 29.92% (25.79–34.05) and 66.20 (55.43–76.97). The subgroup analysis of this systematic review further revealed that the highest prevalence was observed in Oromia (31.62%) and Amhara (31.56%). The isolated bacteria were more resistant to penicillin groups, cephalosporins, and aminoglycosides. Preterm birth AOR = 8.2, 95%CI: 1.12–15.77), premature rupture of membranes (AOR = 4.8, 95%CI: 3.17–12.77), history of urinary tract infection at antenatal care (AOR = 33.21, 95%; 3.2–63.21), and low birth weight (AOR = 13.73, 95%CI: 4.48–31.95) were significantly associated with bacterial neonatal sepsis. Conclusion: Bacterial neonatal sepsis and MDR have been relatively high. Preterm birth, premature rupture of membranes, history of urinary tract infection at antenatal care, and low birth weight were significantly associated. Implementing antimicrobial stewardship and regular surveillance to control antimicrobial resistance is vital for informing region-specific antibiotic use. Furthermore, early diagnosis and proactive screening for risk factors are key to preventing neonatal sepsis and decreasing its overall burden.